NEW YORK (Reuters Health)—Having a family history of rheumatoid arthritis (RA) does not appear to influence the clinical presentation or treatment response of RA to standard medications, researchers from Sweden report. “At first we were a bit surprised by our findings,” Dr. Thomas Frisell from Karolinska Institutet in Stockholm told Reuters Health by email. “Patients…
Nurses May Be Key to Long-Term Clinical Trial Success
After completing a 10-year clinical trial examining treatment strategies for rheumatoid arthritis, Dutch researchers used a questionnaire to determine the study conditions and individual motivators that kept 60% of patients participating long term…
Ixekizumab Clinical Trials Continue; FDA Updates Warning Label for Varenicline
It seems to have begun in Norway, the international pressure to switch patients from well-known brand biologic agents, such as Remicade (infliximab), to biosimilar agents, due to a significant cost advantage.1 This biosimilar came with a 39% price markdown last year compared with the brand, and when Norway called for bids, the discount went to…
An Identity Crisis for RA
A few suggestions to bring rheumatic disease the recognition and respect it deserves
Pain Management for the Person with RA: An Occupational Therapist’s Perspective
RA is a chronic disease that people must learn to live with for their lifetime. Occupational therapists (OTs) play a pivotal role in assisting patients with RA with functioning in the face of a disease that causes limitations and deformities.
How Energy Shifts Lead to Systemic Illness
The impact of adaptive energy programs on the manifestations of chronic inflammatory disease
Russians Mourn Iconic Rheumatologist
Valentina A. Nasonova, MD, was Renaissance figure in Russian rheumatology
RA Treatment May Be Beneficial Even After Patients Meet Remission Criteria
An analysis of wrist MRIs from participants in the Treatment of Early Aggressive Rheumatoid Arthritis (TEAR) clinical trial indicates that patients continue to show joint inflammation even after two years of early aggressive therapy.
Treat Rheumatoid Arthritis to Target
The time has come for goal-directed management of RA
New Criteria for RA Remission
ACR and EULAR update 1981 criteria to reflect modern treatment options
- « Previous Page
- 1
- …
- 25
- 26
- 27
- 28
- 29
- 30
- Next Page »